We are live on ! Find out more
GNCA

Genocea Biosciences, Inc.
GNCA

Delisted

GNCA was delisted on the 2nd of June, 2022.

Back to rankings

1 hedge funds and large institutions have $1 invested in Genocea Biosciences, Inc. in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MPCA
1
Madison Park Capital Advisors
Washington
$1 +$1 +10,000 New

GNCA Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q4 2023, worth a combined $1.

Buyers outnumbered sellers: 1 fund opened new GNCA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Genocea Biosciences, Inc. (GNCA) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $1 of Genocea Biosciences, Inc. stock for Q4 2023.
  • 1 fund opened new Genocea Biosciences, Inc. positions in Q4 2023 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2023.